Cardio3 BioSciences Has Been Selected to Present C3BS-CQR-1 Trial Data in Late … – MarketWatch (press release)
Cardio3 BioSciences Has Been Selected to Present C3BS-CQR-1 Trial Data in Late …MarketWatch (press release)André Terzic, MD, Ph.D, Director at Center of Regenerative Medicine, Mayo Clinic, the co-lead investigator on the trial, will present new fina…
